Tag: pharma news

Tepezza receives approval; a new way to treat Alzheimer’s; and a new anti-obesity molecule

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye...

Read More

Thumbs down to NKTR-181, Lilly expands its insulin armamentarium, 23andMe out-licences its drug

Business Consultant, Pharma Consultant, Pharma news

The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain.  The FDA’s...

Read More

Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M

Business Consultant, Pharma Consultant, Pharma news

A biotech company Novome Biotechnologies is developing novel live medicines for chronic diseases, has raised USD 33 Million in Series A...

Read More

Nunaps raises USD 4.2M; Arcutis files for USD 100M IPO; Merck, Pfizer Bavencio’s improves survival in UC

Business Consultant, Pharma Consultant, Pharma news

A South Korean startup therapeutics company Nunaps has successfully raised USD 4.2 Million around 5 billion won in a Series A round. ...

Read More

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Business Consultant, DelveInsight's Drug Report, Pharma Consultant, The Business Cocktail

Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular...

Read More

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More
Close